Search filters

List of works by Miguel Quintela-Fandino

18F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial.

scientific article published in September 2016

Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance

scientific article

Antiangiogenic Resistance and Cancer Metabolism: Opportunities for Synthetic Lethality

scientific article published on 7 March 2016

Antiangiogenics and Hypoxic Response: Role of Fatty Acid Synthase Inhibitors.

scientific article published on 2 May 2016

Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support.

scientific article

CX3CL1 promotes breast cancer via transactivation of the EGF pathway

scientific article

Coexistence of two rare sarcomas: primary leiomyosarcoma of bone and epithelioid hemangioendothelioma of the liver.

scientific article published on January 2008

Critically short telomeres and toxicity of chemotherapy in early breast cancer

scientific article

DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.

scientific article published on 8 August 2006

Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets.

scientific article published on 16 November 2009

Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells

scientific article published on 01 November 2019

Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial

scientific article published on 11 November 2020

In vivo RAF signal transduction as a potential biomarker for sorafenib efficacy in patients with neuroendocrine tumours.

scientific article published on 14 February 2013

In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer

scientific article published in Nature Communications

Monitoring vascular normalization induced by antiangiogenic treatment with (18)F-fluoromisonidazole-PET.

scientific article published on 22 December 2015

Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition

scientific article published on 24 May 2019

Normoxic or hypoxic adaptation in response to antiangiogenic therapy: Clinical implications.

scientific article published on 19 September 2016

Personalising and targeting antiangiogenic resistance: a complex and multifactorial approach

scientific article

Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study).

scientific article published on 24 July 2014

Phase I combination of sorafenib and erlotinib therapy in solid tumors: safety, pharmacokinetic, and pharmacodynamic evaluation from an expansion cohort

scientific article

Phase II trial of vinorelbine tartrate in patients with treatment-naive metastatic melanoma.

scientific article published in January 2005

Prediction of response to targeted therapies in lung cancer using dynamic imaging: still far from clinical implementation.

scientific article published on 22 August 2011

Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in Early HER2-Negative Breast Cancer

scientific article published on 09 October 2019

Revisiting the Revolution: Examining the Evolving Role of Antiangiogenic Therapy in Cancer

scientific article published in January 2016

Selective activity over a constitutively active RET-variant of the oral multikinase inhibitor dovitinib: results of the CNIO-BR002 phase I-trial ⬇️

scientific article

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

scientific article

Targeting Tumor Mitochondrial Metabolism Overcomes Resistance to Antiangiogenics.

scientific article published on 7 June 2016

Targeting cytoskeleton reorganisation as antimetastatic treatment.

scientific article published on October 2010

The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk ⬇️

scientific article (publication date: 16 February 2012)

Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer.

scientific article published on 11 December 2017

Weekly docetaxel in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

scientific article published on 01 January 2006

[Severe metabolic acidosis in a patient treated with trimethoprim-sulfamethoxazole. Physiopathological facts]

scientific article published on 01 August 2003

Paulina is supported by:

About Paulina

Help